Eisele Johanna, Haynes Geoff, Kreuzer Knut, Hall Caroline
Evonik Nutrition & Care GmbH, Kirschenallee, 64293 Darmstadt, Federal Republic of Germany.
Haynes Safety Services Ltd, Oakridge, Quarry Lane, Gorsley, Ross-on-Wye, Herefordshire HR9 7SJ, England, UK.
Regul Toxicol Pharmacol. 2016 Dec;82:39-47. doi: 10.1016/j.yrtph.2016.11.009. Epub 2016 Nov 4.
Anionic Methacrylate Copolymer (AMC) is a fully polymerized copolymer used in the pharmaceutical industry as an enteric/delayed-release coating to permit the pH-dependent release of active ingredients in the gastrointestinal tract from oral dosage forms. This function is of potential use for food supplements. Oral administration of radiolabeled copolymer to rats resulted in the detection of chemically unchanged copolymer in the feces, with negligible absorption (<0.1%). AMC is therefore determined not to be bioavailable. Within a genotoxicity test battery AMC did not show any evidence of genotoxicity in bacteria and mammalian cells. Furthermore, no genotoxic effects occurred in vivo within a micronucleus test. There would therefore appear to be no safety concerns under intended conditions of oral use for the discussed toxicological endpoints.
阴离子甲基丙烯酸酯共聚物(AMC)是一种完全聚合的共聚物,在制药行业用作肠溶/缓释包衣,以使口服剂型中的活性成分在胃肠道中实现pH依赖性释放。该功能对食品补充剂具有潜在用途。给大鼠口服放射性标记的共聚物后,在粪便中检测到化学性质未改变的共聚物,吸收可忽略不计(<0.1%)。因此确定AMC无生物利用度。在一组遗传毒性试验中,AMC在细菌和哺乳动物细胞中未显示任何遗传毒性证据。此外,在微核试验中体内未出现遗传毒性作用。因此,在所讨论的毒理学终点的预期口服使用条件下,似乎不存在安全问题。